These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4886340)

  • 1. Failure of "intensain" to improve exercise tolerance in patients with angina pectoris.
    Conway N; Gupta GD; Sowton E
    Acta Cardiol; 1968; 23(5):434-8. PubMed ID: 4886340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Perhexiline maleate in angina pectoris. Study of tolerance to treadmill exercise].
    Souza AD
    Arq Bras Cardiol; 1973 Aug; 26 Suppl 1():83-8. PubMed ID: 4595480
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of five different long-acting nitroglycerine derivatives on angina pectoris].
    Kaltenbach M; Tiedemann I; Schellhorn W
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1479-84. PubMed ID: 4627249
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of coronary dilators].
    Kreuzer H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):186-94. PubMed ID: 4896197
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbochromen in therapy of acute and chronic coronary insufficiency].
    Votcal BE; Lozinskij LG
    Arzneimittelforschung; 1970 Mar; 20():459-60. PubMed ID: 4989254
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensain treatment of patients with ischemic heart disease].
    Savenkov PM; Zharov EI; Arshakuni RO; Martynov AI; Pflug K
    Kardiologiia; 1969 Feb; 9(2):58-66. PubMed ID: 5800187
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with the use of Intensain in the coronary syndrome].
    Ivanchich R; Pershich T; Chustovich F
    Kardiologiia; 1969 Jul; 9(7):69-73. PubMed ID: 4906448
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of angina pectoris with chromonar hydrochloride.
    Bell H; Azarnoff DL; Dunn M
    Clin Pharmacol Ther; 1968; 9(1):40-4. PubMed ID: 4966194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug therapy using Intensain within rehabilitation in angina pectoris and in condition after myocardial infarct].
    Hupka KH
    Z Allgemeinmed; 1974 Jan; 50(2):90-5. PubMed ID: 4816788
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Effects of perhexiline maleate in angina pectoris: a double-blind clinical evaluation with ECG-treadmill exercise testing.
    Morledge J
    Postgrad Med J; 1973 Apr; 49():Suppl 3:64-7. PubMed ID: 4587034
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind clinical and ECG-evaluation of lidoflazine (R 7904) in the treatment of stabilized angina pectoris.
    Keulen UW
    Curr Med Res Opin; 1973; 1(8):469-81. PubMed ID: 4589632
    [No Abstract]   [Full Text] [Related]  

  • 12. [Verapamil in the treatment of angina pectoris. Comparative double-blind study with fendilin].
    Albuquerque DC; Schlesinger P; Benchimol CB; Albanesi FM; Benchimol AB
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():63-7. PubMed ID: 354613
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of a clinical study of the therapeutic effect of intensain in chronic coronary insufficiency].
    Shkhvatsabaia IK; Miasnikov LA; Metelitsa VI; Grigor'iants RA
    Kardiologiia; 1969 Feb; 9(2):66-70. PubMed ID: 4895292
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of perhexiline maleate in patients with angina pectoris unrelieved by other antianginal agent.
    Alcocer L; Aspe J; Arce-Gomez E
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):349-57. PubMed ID: 4198295
    [No Abstract]   [Full Text] [Related]  

  • 15. [Paired bicycle exercise test in assessment of clinical efficacy of isosorbide-5-mononitrate in patients with stable angina of effort].
    Belenkov IuN; Ageev FT; Nuraliev EIu; Prostakova TS; Dzhakhangirov TSh
    Kardiologiia; 2005; 45(9):11-5. PubMed ID: 16234785
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic and therapeutic effect of BAY a 1040 on the patients with ischemic heart disease.
    Hayase S; Hirakawa S; Hosokawa S; Mori N; Kanyama S
    Arzneimittelforschung; 1972 Feb; 22(2):370-3. PubMed ID: 4554632
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of acute digitalization to influence exercise tolerance in angina pectoris.
    Smith HJ; Bousvaros GA; McGregor M
    Br Med J; 1966 May; 1(5499):1337-8. PubMed ID: 5327222
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Influence of perhexiline on the effort tolerance test in angina pectoris. Comparison with placebo and prenylamine.
    Cherchi A; Bina M; Fonzo R; Raffo M
    Postgrad Med J; 1973 Apr; 49():Suppl 3:67-74. PubMed ID: 4587035
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigation of verapamil in the treatment of angina pectoris.
    Sandler G
    Brux Med; 1970 Sep; 50(9):669-73. PubMed ID: 4928626
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E; Mabuchi G; Kikuchi H
    Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.